These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 10877449
1. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects. Grzegorczyk J, Majkowska-Wojciechowska B, Kowalski ML. Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449 [Abstract] [Full Text] [Related]
2. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide. Lantero S, Sacco O, Scala C, Morelli MC, Rossi GA. Clin Exp Allergy; 1996 Jun; 26(6):656-64. PubMed ID: 8809423 [Abstract] [Full Text] [Related]
3. [Inhibitory effects of cyclosporin A and FK-506 on eosinophil chemotactic factor activity in culture supernatants of mononuclear cells from asthmatics]. Akutsu I, Fukuda T, Makino S. Arerugi; 1992 Jul; 41(7):778-86. PubMed ID: 1280086 [Abstract] [Full Text] [Related]
4. Specific immunotherapy reduces the antigen-dependent production of eosinophil chemotactic activity from mononuclear cells in patients with atopic asthma. Nagata M, Shibasaki M, Sakamoto Y, Fukuda T, Makino S, Yamamoto K, Dohi Y. J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):160-6. PubMed ID: 8064068 [Abstract] [Full Text] [Related]
5. [Chemotactic serum activity for neutrophils and eosinophils and spontaneous production of histamine releasing factor in patients with seasonal bronchial asthma treated with nedocromil sodium]. Grzelewska-Rzymowska I, Grzegorczyk J, Grabski W, Kroczyńska-Bednarek J, Kuźmińska B, Rozniecki J. Pneumonol Alergol Pol; 1996 Aug; 64(3-4):132-40. PubMed ID: 8754956 [Abstract] [Full Text] [Related]
6. Immunotherapy attenuates eosinophil transendothelial migration induced by the supernatants of antigen-stimulated mononuclear cells from atopic asthmatics. Nagata M, Saito K, Kikuchi I, Tabe K, Hagiwara K, Kanazawa M, Sakamoto Y. Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():21-4. PubMed ID: 15166479 [Abstract] [Full Text] [Related]
7. [Eosinophil chemotactic activity in the supernatant of mononuclear cell culture stimulated with specific antigen]. Fukushima Y, Fukuda T, Makino S. Arerugi; 1991 Feb; 40(2):108-16. PubMed ID: 2069510 [Abstract] [Full Text] [Related]
9. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. Raap U, Goltz C, Deneka N, Bruder M, Renz H, Kapp A, Wedi B. J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146 [Abstract] [Full Text] [Related]
10. Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Hemelaers L, Henket M, Sele J, Bureau F, Louis R. Allergy; 2006 Jan; 61(1):136-9. PubMed ID: 16364169 [Abstract] [Full Text] [Related]
11. Methotrexate stimulates lung fibroblasts and epithelial cells to release eosinophil chemotactic activity. Sato E, Camhi SL, Koyama S, Robbins RA. J Rheumatol; 2001 Mar; 28(3):502-8. PubMed ID: 11296949 [Abstract] [Full Text] [Related]
16. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis. Sale R, Sabatini F, Silvestri M, Serpero L, Petecchia L, Rossi GA. Int Immunopharmacol; 2004 Dec 15; 4(13):1687-96. PubMed ID: 15454120 [Abstract] [Full Text] [Related]